Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis-a unique therapeutic target in inflammatory bowel disease

Aliment Pharmacol Ther. 2022 May;55(10):1359. doi: 10.1111/apt.16888.

Authors

Heinfried H Radeke^{1

2}, Jürgen Stein^{1

3

4}

Affiliations

¹ Interdisziplinäres Crohn-Colitis Centrum Rhein-Main, Frankfurt am Main, Germany.
² pharmazentrum frankfurt, Institute of Pharmacology and Toxicology, Hospital of the Goethe University, Frankfurt am Main, Germany.
³ Gastroenterology and Clinical Nutrition, DGD Kliniken Sachsenhausen, Frankfurt am Main, Germany.
⁴ Institute of Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.

PMID: 35472180
DOI: 10.1111/apt.16888

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Inflammatory Bowel Diseases* / drug therapy
Inflammatory Bowel Diseases* / metabolism
Lysophospholipids* / metabolism
Molecular Targeted Therapy
Signal Transduction / drug effects
Sphingosine / analogs & derivatives*
Sphingosine / metabolism
Sphingosine-1-Phosphate Receptors* / metabolism

Substances

Lysophospholipids
Sphingosine-1-Phosphate Receptors
sphingosine 1-phosphate
Sphingosine